Selected research
Market Outlook & Growth Opportunities
Global Sterile Biologics Filling Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Sterile Biologics Filling Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Sterile Biologics Filling Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sterile Biologics Filling Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sterile Biologics Filling Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Sterile Biologics Filling Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Sterile Biologics Filling Services market include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier and Bushu Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Sterile Biologics Filling Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sterile Biologics Filling Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sterile Biologics Filling Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Sterile Biologics Filling Services market.
Sterile Biologics Filling Services Segment by Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Sterile Biologics Filling Services Segment by Type
0.2-1ml
1-5ml
>5ml
Sterile Biologics Filling Services Segment by Application
Vaccines
Biologics and Biosimilar
Others
Sterile Biologics Filling Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Sterile Biologics Filling Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Sterile Biologics Filling Services key companies, revenue, market share, and recent developments.
3. To split the Sterile Biologics Filling Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Sterile Biologics Filling Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Sterile Biologics Filling Services significant trends, drivers, influence factors in global and regions.
6. To analyze Sterile Biologics Filling Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Biologics Filling Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sterile Biologics Filling Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Biologics Filling Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sterile Biologics Filling Services industry.
Chapter 3: Detailed analysis of Sterile Biologics Filling Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Sterile Biologics Filling Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Sterile Biologics Filling Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2-1ml
- 1-5ml
- >5ml
Applications
- Vaccines
- Biologics and Biosimilar
- Others
Companies covered
- Baxter BioPharma Solutions
- Boehringer Ingelheim
- Vetter Pharma
- Fresenius Kabi
- Pfizer CentreOne
- Aenova
- WuXi Biologics
- Jubilant HollisterStier
- Bushu Pharmaceuticals
- LSNE Contract Manufacturing
- Ajinomoto Bio-Pharma Services
- CMIC CMO
- GRAM (Grand River Aseptic Manufacturing)
- TAIYO Pharma Tech
- HALIX
- Cognate BioServices
- Afton Scientific
- Novasep
- Emergent BioSolutions
- Seikagaku
- Jiangshu YAOHAI Bio-pharmaceutical
- Akron Biotech
- Symbiosis Pharmaceutical Services
- Techdow
- Vigene Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sterile Biologics Filling Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sterile Biologics Filling Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sterile Biologics Filling Services Market Dynamics
- 2.1 Sterile Biologics Filling Services Industry Trends
- 2.2 Sterile Biologics Filling Services Industry Drivers
- 2.3 Sterile Biologics Filling Services Industry Opportunities and Challenges
- 2.4 Sterile Biologics Filling Services Industry Restraints
3 Sterile Biologics Filling Services Market by Company
- 3.1 Global Sterile Biologics Filling Services Company Revenue Ranking in 2025
- 3.2 Global Sterile Biologics Filling Services Revenue by Company (2021-2026)
- 3.3 Global Sterile Biologics Filling Services Company Ranking (2024-2026)
- 3.4 Global Sterile Biologics Filling Services Company Manufacturing Base and Headquarters
- 3.5 Global Sterile Biologics Filling Services Company Product Type and Application
- 3.6 Global Sterile Biologics Filling Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Sterile Biologics Filling Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Sterile Biologics Filling Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Sterile Biologics Filling Services Market by Type
- 4.1 Sterile Biologics Filling Services Type Introduction
- 4.1.1 0.2-1ml
- 4.1.2 1-5ml
- 4.1.3 >5ml
- 4.2 Global Sterile Biologics Filling Services Sales Value by Type
- 4.2.1 Global Sterile Biologics Filling Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sterile Biologics Filling Services Sales Value by Type (2021-2032)
- 4.2.3 Global Sterile Biologics Filling Services Sales Value Share by Type (2021-2032)
5 Sterile Biologics Filling Services Market by Application
- 5.1 Sterile Biologics Filling Services Application Introduction
- 5.1.1 Vaccines
- 5.1.2 Biologics and Biosimilar
- 5.1.3 Others
- 5.2 Global Sterile Biologics Filling Services Sales Value by Application
- 5.2.1 Global Sterile Biologics Filling Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sterile Biologics Filling Services Sales Value by Application (2021-2032)
- 5.2.3 Global Sterile Biologics Filling Services Sales Value Share by Application (2021-2032)
6 Sterile Biologics Filling Services Regional Value Analysis
- 6.1 Global Sterile Biologics Filling Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sterile Biologics Filling Services Sales Value by Region (2021-2032)
- 6.2.1 Global Sterile Biologics Filling Services Sales Value by Region: 2021-2026
- 6.2.2 Global Sterile Biologics Filling Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sterile Biologics Filling Services Sales Value (2021-2032)
- 6.3.2 North America Sterile Biologics Filling Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Sterile Biologics Filling Services Sales Value (2021-2032)
- 6.4.2 Europe Sterile Biologics Filling Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Sterile Biologics Filling Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Sterile Biologics Filling Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Sterile Biologics Filling Services Sales Value (2021-2032)
- 6.6.2 South America Sterile Biologics Filling Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Sterile Biologics Filling Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Sterile Biologics Filling Services Sales Value Share by Country, 2025 VS 2032
7 Sterile Biologics Filling Services Country-level Value Analysis
- 7.1 Global Sterile Biologics Filling Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Sterile Biologics Filling Services Sales Value by Country (2021-2032)
- 7.2.1 Global Sterile Biologics Filling Services Sales Value by Country (2021-2026)
- 7.2.2 Global Sterile Biologics Filling Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Sterile Biologics Filling Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Sterile Biologics Filling Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Sterile Biologics Filling Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Baxter BioPharma Solutions
- 8.1.1 Baxter BioPharma Solutions Company Information
- 8.1.2 Baxter BioPharma Solutions Business Overview
- 8.1.3 Baxter BioPharma Solutions Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Baxter BioPharma Solutions Sterile Biologics Filling Services Product Portfolio
- 8.1.5 Baxter BioPharma Solutions Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Sterile Biologics Filling Services Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Vetter Pharma
- 8.3.1 Vetter Pharma Company Information
- 8.3.2 Vetter Pharma Business Overview
- 8.3.3 Vetter Pharma Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Vetter Pharma Sterile Biologics Filling Services Product Portfolio
- 8.3.5 Vetter Pharma Recent Developments
- 8.4 Fresenius Kabi
- 8.4.1 Fresenius Kabi Company Information
- 8.4.2 Fresenius Kabi Business Overview
- 8.4.3 Fresenius Kabi Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Fresenius Kabi Sterile Biologics Filling Services Product Portfolio
- 8.4.5 Fresenius Kabi Recent Developments
- 8.5 Pfizer CentreOne
- 8.5.1 Pfizer CentreOne Company Information
- 8.5.2 Pfizer CentreOne Business Overview
- 8.5.3 Pfizer CentreOne Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer CentreOne Sterile Biologics Filling Services Product Portfolio
- 8.5.5 Pfizer CentreOne Recent Developments
- 8.6 Aenova
- 8.6.1 Aenova Company Information
- 8.6.2 Aenova Business Overview
- 8.6.3 Aenova Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Aenova Sterile Biologics Filling Services Product Portfolio
- 8.6.5 Aenova Recent Developments
- 8.7 WuXi Biologics
- 8.7.1 WuXi Biologics Company Information
- 8.7.2 WuXi Biologics Business Overview
- 8.7.3 WuXi Biologics Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.7.4 WuXi Biologics Sterile Biologics Filling Services Product Portfolio
- 8.7.5 WuXi Biologics Recent Developments
- 8.8 Jubilant HollisterStier
- 8.8.1 Jubilant HollisterStier Company Information
- 8.8.2 Jubilant HollisterStier Business Overview
- 8.8.3 Jubilant HollisterStier Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Jubilant HollisterStier Sterile Biologics Filling Services Product Portfolio
- 8.8.5 Jubilant HollisterStier Recent Developments
- 8.9 Bushu Pharmaceuticals
- 8.9.1 Bushu Pharmaceuticals Company Information
- 8.9.2 Bushu Pharmaceuticals Business Overview
- 8.9.3 Bushu Pharmaceuticals Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Bushu Pharmaceuticals Sterile Biologics Filling Services Product Portfolio
- 8.9.5 Bushu Pharmaceuticals Recent Developments
- 8.10 LSNE Contract Manufacturing
- 8.10.1 LSNE Contract Manufacturing Company Information
- 8.10.2 LSNE Contract Manufacturing Business Overview
- 8.10.3 LSNE Contract Manufacturing Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.10.4 LSNE Contract Manufacturing Sterile Biologics Filling Services Product Portfolio
- 8.10.5 LSNE Contract Manufacturing Recent Developments
- 8.11 Ajinomoto Bio-Pharma Services
- 8.11.1 Ajinomoto Bio-Pharma Services Company Information
- 8.11.2 Ajinomoto Bio-Pharma Services Business Overview
- 8.11.3 Ajinomoto Bio-Pharma Services Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Ajinomoto Bio-Pharma Services Sterile Biologics Filling Services Product Portfolio
- 8.11.5 Ajinomoto Bio-Pharma Services Recent Developments
- 8.12 CMIC CMO
- 8.12.1 CMIC CMO Company Information
- 8.12.2 CMIC CMO Business Overview
- 8.12.3 CMIC CMO Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.12.4 CMIC CMO Sterile Biologics Filling Services Product Portfolio
- 8.12.5 CMIC CMO Recent Developments
- 8.13 GRAM (Grand River Aseptic Manufacturing)
- 8.13.1 GRAM (Grand River Aseptic Manufacturing) Company Information
- 8.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
- 8.13.3 GRAM (Grand River Aseptic Manufacturing) Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.13.4 GRAM (Grand River Aseptic Manufacturing) Sterile Biologics Filling Services Product Portfolio
- 8.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Developments
- 8.14 TAIYO Pharma Tech
- 8.14.1 TAIYO Pharma Tech Company Information
- 8.14.2 TAIYO Pharma Tech Business Overview
- 8.14.3 TAIYO Pharma Tech Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.14.4 TAIYO Pharma Tech Sterile Biologics Filling Services Product Portfolio
- 8.14.5 TAIYO Pharma Tech Recent Developments
- 8.15 HALIX
- 8.15.1 HALIX Company Information
- 8.15.2 HALIX Business Overview
- 8.15.3 HALIX Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.15.4 HALIX Sterile Biologics Filling Services Product Portfolio
- 8.15.5 HALIX Recent Developments
- 8.16 Cognate BioServices
- 8.16.1 Cognate BioServices Company Information
- 8.16.2 Cognate BioServices Business Overview
- 8.16.3 Cognate BioServices Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.16.4 Cognate BioServices Sterile Biologics Filling Services Product Portfolio
- 8.16.5 Cognate BioServices Recent Developments
- 8.17 Afton Scientific
- 8.17.1 Afton Scientific Company Information
- 8.17.2 Afton Scientific Business Overview
- 8.17.3 Afton Scientific Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Afton Scientific Sterile Biologics Filling Services Product Portfolio
- 8.17.5 Afton Scientific Recent Developments
- 8.18 Novasep
- 8.18.1 Novasep Company Information
- 8.18.2 Novasep Business Overview
- 8.18.3 Novasep Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Novasep Sterile Biologics Filling Services Product Portfolio
- 8.18.5 Novasep Recent Developments
- 8.19 Emergent BioSolutions
- 8.19.1 Emergent BioSolutions Company Information
- 8.19.2 Emergent BioSolutions Business Overview
- 8.19.3 Emergent BioSolutions Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.19.4 Emergent BioSolutions Sterile Biologics Filling Services Product Portfolio
- 8.19.5 Emergent BioSolutions Recent Developments
- 8.20 Seikagaku
- 8.20.1 Seikagaku Company Information
- 8.20.2 Seikagaku Business Overview
- 8.20.3 Seikagaku Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Seikagaku Sterile Biologics Filling Services Product Portfolio
- 8.20.5 Seikagaku Recent Developments
- 8.21 Jiangshu YAOHAI Bio-pharmaceutical
- 8.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Information
- 8.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
- 8.21.3 Jiangshu YAOHAI Bio-pharmaceutical Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.21.4 Jiangshu YAOHAI Bio-pharmaceutical Sterile Biologics Filling Services Product Portfolio
- 8.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Developments
- 8.22 Akron Biotech
- 8.22.1 Akron Biotech Company Information
- 8.22.2 Akron Biotech Business Overview
- 8.22.3 Akron Biotech Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.22.4 Akron Biotech Sterile Biologics Filling Services Product Portfolio
- 8.22.5 Akron Biotech Recent Developments
- 8.23 Symbiosis Pharmaceutical Services
- 8.23.1 Symbiosis Pharmaceutical Services Company Information
- 8.23.2 Symbiosis Pharmaceutical Services Business Overview
- 8.23.3 Symbiosis Pharmaceutical Services Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.23.4 Symbiosis Pharmaceutical Services Sterile Biologics Filling Services Product Portfolio
- 8.23.5 Symbiosis Pharmaceutical Services Recent Developments
- 8.24 Techdow
- 8.24.1 Techdow Company Information
- 8.24.2 Techdow Business Overview
- 8.24.3 Techdow Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.24.4 Techdow Sterile Biologics Filling Services Product Portfolio
- 8.24.5 Techdow Recent Developments
- 8.25 Vigene Biosciences
- 8.25.1 Vigene Biosciences Company Information
- 8.25.2 Vigene Biosciences Business Overview
- 8.25.3 Vigene Biosciences Sterile Biologics Filling Services Revenue and Gross Margin (2021-2026)
- 8.25.4 Vigene Biosciences Sterile Biologics Filling Services Product Portfolio
- 8.25.5 Vigene Biosciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst